{
 "companyname": "XOMA CORP",
 "symbol": "XOMA",
 "description": "Pharmaceutical Preparations",
 "quarters": [
  {
   "cik": "0000791908",
   "companyname": "XOMA CORP",
   "entityid": 1361,
   "primaryexchange": "Nasdaq Global Market",
   "primarysymbol": "XOMA",
   "siccode": "2834",
   "sicdescription": "Pharmaceutical Preparations",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "11/6/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "9/30/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 3,
   "dcn": "0001564590-15-009798",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": -37455000,
   "changeincurrentliabilities": 3589000,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": 14000,
   "capitalexpenditures": -60000,
   "cashfromfinancingactivities": 149000,
   "cashfrominvestingactivities": -42000,
   "cashfromoperatingactivities": -19032000,
   "cfdepreciationamortization": 791000,
   "changeinaccountsreceivable": -36694000,
   "investmentchangesnet": 0,
   "netchangeincash": -18911000,
   "totaladjustments": -18551000,
   "ebit": -23678000,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": 2074000,
   "incomebeforetaxes": -480000,
   "interestexpense": -1030000,
   "netincome": -480000,
   "netincomeapplicabletocommon": -480000,
   "researchdevelopmentexpense": 17559000,
   "totalrevenue": 2074000,
   "sellinggeneraladministrativeexpenses": 5632000,
   "commonstock": 891000,
   "deferredcharges": null,
   "cashandcashequivalents": 32046000,
   "cashcashequivalentsandshortterminvestments": 32046000,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": 664000,
   "othercurrentassets": null,
   "othercurrentliabilities": 4123000,
   "otherequity": null,
   "otherliabilities": 4619000,
   "preferredstock": 0,
   "propertyplantequipmentnet": 4097000,
   "retainedearnings": -1165435000,
   "totalassets": 79028000,
   "totalcurrentassets": 74267000,
   "totalcurrentliabilities": 59137000,
   "totalliabilities": 108218000,
   "totallongtermdebt": 44462000,
   "totalreceivablesnet": 39343000,
   "totalshorttermdebt": null,
   "totalstockholdersequity": -29190000,
   "treasurystock": null
  },
  {
   "cik": "0000791908",
   "companyname": "XOMA CORP",
   "entityid": 1361,
   "primaryexchange": "Nasdaq Global Market",
   "primarysymbol": "XOMA",
   "siccode": "2834",
   "sicdescription": "Pharmaceutical Preparations",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "8/10/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "6/30/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 2,
   "dcn": "0001140361-15-030673",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": 366000,
   "changeincurrentliabilities": 2664000,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": -4000,
   "capitalexpenditures": -181000,
   "cashfromfinancingactivities": -2000,
   "cashfrominvestingactivities": -181000,
   "cashfromoperatingactivities": -16347000,
   "cfdepreciationamortization": 804000,
   "changeinaccountsreceivable": 622000,
   "investmentchangesnet": null,
   "netchangeincash": -16534000,
   "totaladjustments": 7412000,
   "ebit": -22213000,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": 2539000,
   "incomebeforetaxes": -23759000,
   "interestexpense": -1007000,
   "netincome": -23759000,
   "netincomeapplicabletocommon": -23759000,
   "researchdevelopmentexpense": 19692000,
   "totalrevenue": 2539000,
   "sellinggeneraladministrativeexpenses": 5060000,
   "commonstock": 885000,
   "deferredcharges": null,
   "cashandcashequivalents": 50957000,
   "cashcashequivalentsandshortterminvestments": 50957000,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": 665000,
   "othercurrentassets": null,
   "othercurrentliabilities": 15793000,
   "otherequity": null,
   "otherliabilities": 29512000,
   "preferredstock": 0,
   "propertyplantequipmentnet": 4455000,
   "retainedearnings": -1164954000,
   "totalassets": 60843000,
   "totalcurrentassets": 55723000,
   "totalcurrentliabilities": 29674000,
   "totalliabilities": 92129000,
   "totallongtermdebt": 32211000,
   "totalreceivablesnet": 2649000,
   "totalshorttermdebt": null,
   "totalstockholdersequity": -31286000,
   "treasurystock": null
  },
  {
   "cik": "0000791908",
   "companyname": "XOMA CORP",
   "entityid": 1361,
   "primaryexchange": "Nasdaq Global Market",
   "primarysymbol": "XOMA",
   "siccode": "2834",
   "sicdescription": "Pharmaceutical Preparations",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "5/7/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "3/31/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 1,
   "dcn": "0001140361-15-018207",
   "currencycode": "USD",
   "crosscalculated": false,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": 36000,
   "changeincurrentliabilities": -6618000,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": -23000,
   "capitalexpenditures": -225000,
   "cashfromfinancingactivities": 13574000,
   "cashfrominvestingactivities": -225000,
   "cashfromoperatingactivities": -24280000,
   "cfdepreciationamortization": 754000,
   "changeinaccountsreceivable": 38000,
   "investmentchangesnet": null,
   "netchangeincash": -10954000,
   "totaladjustments": -2562000,
   "ebit": -22573000,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": 2651000,
   "incomebeforetaxes": -21718000,
   "interestexpense": -1115000,
   "netincome": -21718000,
   "netincomeapplicabletocommon": -21718000,
   "researchdevelopmentexpense": 20004000,
   "totalrevenue": 2651000,
   "sellinggeneraladministrativeexpenses": 5220000,
   "commonstock": 877000,
   "deferredcharges": null,
   "cashandcashequivalents": 67491000,
   "cashcashequivalentsandshortterminvestments": 67491000,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": 664000,
   "othercurrentassets": null,
   "othercurrentliabilities": 15605000,
   "otherequity": null,
   "otherliabilities": 31868000,
   "preferredstock": 0,
   "propertyplantequipmentnet": 4783000,
   "retainedearnings": -1141195000,
   "totalassets": 78069000,
   "totalcurrentassets": 72622000,
   "totalcurrentliabilities": 26427000,
   "totalliabilities": 91453000,
   "totallongtermdebt": 31584000,
   "totalreceivablesnet": 3271000,
   "totalshorttermdebt": null,
   "totalstockholdersequity": -13384000,
   "treasurystock": null
  }
 ]
}